JPMorgan Chase & Co. Acquires 37,107 Shares of Acadia Healthcare Company, Inc. $ACHC

JPMorgan Chase & Co. boosted its holdings in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 22.3% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 203,658 shares of the company’s stock after acquiring an additional 37,107 shares during the period. JPMorgan Chase & Co.’s holdings in Acadia Healthcare were worth $5,043,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. EverSource Wealth Advisors LLC increased its position in shares of Acadia Healthcare by 54.8% during the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Hantz Financial Services Inc. lifted its position in Acadia Healthcare by 501.9% in the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock valued at $54,000 after acquiring an additional 1,822 shares in the last quarter. Quent Capital LLC acquired a new position in Acadia Healthcare during the 3rd quarter valued at about $71,000. Steward Partners Investment Advisory LLC boosted its stake in Acadia Healthcare by 639.5% during the 2nd quarter. Steward Partners Investment Advisory LLC now owns 3,372 shares of the company’s stock valued at $77,000 after purchasing an additional 2,916 shares during the last quarter. Finally, Covestor Ltd increased its holdings in Acadia Healthcare by 36.0% during the 3rd quarter. Covestor Ltd now owns 6,004 shares of the company’s stock worth $149,000 after purchasing an additional 1,589 shares in the last quarter.

Acadia Healthcare Price Performance

Shares of NASDAQ ACHC opened at $23.67 on Thursday. The company has a market capitalization of $2.18 billion, a PE ratio of -1.94, a PEG ratio of 7.90 and a beta of 0.71. The company has a quick ratio of 1.55, a current ratio of 1.55 and a debt-to-equity ratio of 1.27. The stock’s 50 day moving average price is $19.42 and its 200-day moving average price is $18.80. Acadia Healthcare Company, Inc. has a twelve month low of $11.43 and a twelve month high of $30.17.

Acadia Healthcare (NASDAQ:ACHC) last issued its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 EPS for the quarter, beating analysts’ consensus estimates of $0.03 by $0.04. The company had revenue of $821.46 million during the quarter, compared to the consensus estimate of $800.10 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.Acadia Healthcare’s revenue was up 6.1% on a year-over-year basis. During the same period last year, the business posted $0.64 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. On average, equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

Analyst Ratings Changes

ACHC has been the topic of a number of recent research reports. Barclays raised their target price on Acadia Healthcare from $14.00 to $20.00 and gave the company an “equal weight” rating in a report on Tuesday, March 3rd. Raymond James Financial reissued an “outperform” rating and issued a $25.00 price target on shares of Acadia Healthcare in a research report on Thursday, February 26th. Guggenheim dropped their price objective on Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating on the stock in a research note on Monday, February 23rd. Cantor Fitzgerald set a $17.00 price objective on shares of Acadia Healthcare in a report on Wednesday, December 3rd. Finally, TD Cowen upped their target price on shares of Acadia Healthcare from $22.00 to $24.00 and gave the stock a “buy” rating in a research note on Thursday, February 26th. Seven research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and a consensus target price of $21.15.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.